EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-814 Cr |
| Mar2024 | ₹-164 Cr |
| Mar2023 | ₹-145 Cr |
| Mar2022 | ₹-152 Cr |
| Mar2021 | ₹-189 Cr |
How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-814 Cr | Negative | |
| Mar2024 | ₹-164 Cr | Negative | |
| Mar2023 | ₹-145 Cr | Negative | |
| Mar2022 | ₹-152 Cr | Negative | |
| Mar2021 | ₹-189 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,249.3 Cr | 7% | 0.1% | 59.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 7% |
0.1% |
59.1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses